Literature DB >> 14966480

Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus.

A P Corvin1, D W Morris, K McGhee, S Schwaiger, P Scully, J Quinn, D Meagher, D St Clair, J L Waddington, M Gill.   

Abstract

Two recent association studies have implicated the neuregulin-1 gene (NRG1) at chromosome 8p21-22 as a susceptibility gene for schizophrenia. Stefansson et al identified three 'at-risk' haplotypes (HapA, B and C) which spanned the NRG1 locus and shared a common core haplotype. Subsequently, they demonstrated evidence that the core haplotype was associated with schizophrenia in an independent Scottish sample. To confirm and refine this haplotype we investigated the NRG1 locus in an independent Irish case-control sample. We did not find the core haplotype to be associated in our sample. However, we identified a refined 2-marker haplotype (HapB(IRE)) that shared common alleles with one of the Icelandic 'at-risk' haplotypes and is in significant excess in the Irish cases (19.4%) vs controls (12.3%) (P=0.013). This refined 'at-risk' haplotype is also in significant excess in the Scottish case sample (17.0% vs 13.5%; P=0.036). Interestingly, this refined 'at-risk' haplotype is positioned close to an EST cluster of unknown function (Hs.97362) within intron 1 of NRG1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966480     DOI: 10.1038/sj.mp.4001412

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  34 in total

1.  Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Authors:  Kristin K Nicodemus; Amanda J Law; Eugenia Radulescu; Augustin Luna; Bhaskar Kolachana; Radhakrishna Vakkalanka; Dan Rujescu; Ina Giegling; Richard E Straub; Kate McGee; Bert Gold; Michael Dean; Pierandrea Muglia; Joseph H Callicott; Hao-Yang Tan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-10

Review 2.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

Review 3.  Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.

Authors:  Kristen J Brennand; Fred H Gage
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

4.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Sarah S Murray; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Raquel E Gur; Ruben C Gur; Gary Hardiman; John R Kelsoe; Sherry Leonard; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Robert Freedman; David L Braff
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

5.  Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas.

Authors:  Tilo Kircher; Renate Thienel; Michael Wagner; Martina Reske; Ute Habel; Thilo Kellermann; Ingo Frommann; Sibylle Schwab; Wolfgang Wölwer; Martina von Wilmsdorf; Dieter F Braus; Andrea Schmitt; Alexander Rapp; Tony Stöcker; N Jon Shah; Fritz A Henn; Heinrich Sauer; Wolfgang Gaebel; Wolfgang Maier; Frank Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

6.  Specific regulation of NRG1 isoform expression by neuronal activity.

Authors:  Xihui Liu; Ryan Bates; Dong-Min Yin; Chengyong Shen; Fay Wang; Nan Su; Sergei A Kirov; Yuling Luo; Jian-Zhi Wang; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

7.  Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism.

Authors:  M Shibuya; E Komi; R Wang; T Kato; Y Watanabe; M Sakai; M Ozaki; T Someya; H Nawa
Journal:  J Neural Transm (Vienna)       Date:  2010-06-05       Impact factor: 3.575

Review 8.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Authors:  N Craddock; M C O'Donovan; M J Owen
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

9.  Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development.

Authors:  Clare Paterson; Yanhong Wang; Joel E Kleinman; Amanda J Law
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

Review 10.  Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.

Authors:  Andrea Schmitt; Eleni Parlapani; Oliver Gruber; Thomas Wobrock; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.